In a randomized trial, dexamethasone was shown to improve Hamilton Depression Rating Scale scores in depressed patients compared to placebo over the course of 4 days (168), suggesting that impaired GR activation might contribute to symptoms of depression in some MDD patients. Here, NR3C1 is linked to depressive disorder.